As shown in the present study, we found that the use of a GCS can significantly decrease the level of IL-6 (Table 5), which indicated that the use of a GCS can decrease the inflammatory response in non-HIV-related PJP patients. This evidence concerns the gene IL6 and pneumocystosis.